Senior insider sale
Chief Medical Officer at CORBUS PHARMACEUTICALS HOLDINGS, INC. — senior position signals high conviction
$77.2K
9.38K shares
What this filing means
SMETHURST DOMINIC plans to sell 9.38K shares of CORBUS PHARMACEUTICALS HOLDINGS, INC. valued at approximately $77.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001972481-26-000071
Officer· Chief Medical Officer
Since Mar 2026
9.38K
Shares to sell
$77.2K
Approx. market value
12.50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
2/28/2026
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2026 | Restricted Stock Units Equity Compensation | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.29K
Market value
$26.6K
2/3/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
6.10K
Market value
$50.6K
3/2/2026
Total
Units
9.38K
Value
$77.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 3.29K | $26.6K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 6.10K | $50.6K | Nasdaq | Planned |
| Total | 9.38K | $77.2K | ||